| Date Filed | Type | Description |
| 05/30/2023 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on LENSAR, Inc.|
Txns:
| Granted 9,288 shares
@ $0
Granted 33,175 options to buy
@ $3.23, valued at
$107.2k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Sold 50,000 shares
@ $2.624, valued at
$131.2k
Sold 277,934 shares
@ $2.607, valued at
$724.6k
|
|
| 09/17/2020 |
3
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 3 on LENSAR, Inc. |
| 08/24/2020 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 25,826 shares
@ $0
Granted 118,671 options to buy
@ $3.63, valued at
$430.8k
|
|
| 05/20/2020 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on ROCKWELL MEDICAL, INC.|
Txns:
| Granted 51,800 shares
@ $0
Granted 34,024 options to buy
@ $2.04, valued at
$69.4k
|
|
| 01/31/2020 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on ROCKWELL MEDICAL, INC.|
Txns:
| Granted 12,615 shares
@ $0 |
|
| 09/06/2019 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on ROCKWELL MEDICAL, INC.|
Txns:
| Granted 22,559 shares
@ $0
Granted 28,372 options to buy
@ $2.56, valued at
$72.6k
|
|
| 09/06/2019 |
3
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 3 on ROCKWELL MEDICAL, INC. |
| 07/08/2019 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 126,050 options to buy
@ $3, valued at
$378.2k
|
|
| 01/09/2019 |
4
| MCLAUGHLIN JOHN PETER (CEO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Disposed/sold 123,449 shares
@ $0 |
|
| 12/28/2018 |
4
| MCLAUGHLIN JOHN PETER (CEO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Disposed/sold 627,228 shares
@ $0 |
|
| 06/12/2018 |
4
| MCLAUGHLIN JOHN PETER (CEO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 1,922,100 options to buy
@ $2.94, valued at
$5.7M
|
|
| 12/19/2017 |
4
| MCLAUGHLIN JOHN PETER (CEO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Disposed/sold 151,678 shares
@ $0 |
|
| 03/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/22/2012 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 17,500 options to buy
@ $20.06, valued at
$351.1k
|
|
| 01/20/2012 |
4
| MCLAUGHLIN JOHN PETER (President/Chief Exec. Officer) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 31,955 shares
@ $6.29, valued at
$201k
|
|
| 05/25/2011 |
4
| MCLAUGHLIN JOHN PETER (President and CEO) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 30,501 shares
@ $0 |
|
| 05/24/2011 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA|
Txns:
| Granted 17,500 options to buy
@ $19.02, valued at
$332.9k
|
|
| 05/25/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/16/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2009 |
4
| MCLAUGHLIN JOHN PETER (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA |
| 04/17/2009 |
4/A
| Form 4/A -- Statement of changes in beneficial ownership of securities [amend] |